MRD detection via ctDNA poses challenges in managing breast cancer patients in complete remission, especially when imaging is ...

A homegrown breast cancer therapy has shown promising efficacy and safety in a clinical trial announced on Wednesday by ...

Knowledge is power, and it's also critical for making vital health care decisions. More information leads to better ...

A study presented at a meeting of the Radiological Society of North America found nearly a quarter of all breast cancer cases ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present a total of 14 abstracts with its ...

Dear V.P.: A fibroadenoma is a benign breast mass. Most fibroadenomas are "simple" and do not increase the risk of developing ...

A diagnosis of triple-negative breast cancer is typically made after a biopsy confirms the tumor’s receptor status. Imaging ...

A routine breast cancer screening gave Anabel Cano the all-clear, only for her to discover a year later that her tumor had ...

Fibroadenomas seem to be related to estrogen levels as they tend to occur during a woman's reproductive years.

The findings suggest that the HER2DX assay could help clinicians decide on the appropriate use of chemotherapy in older patients, study researchers wrote.

An image-only artificial intelligence (AI) model for predicting the five-year risk of breast cancer provided stronger and more precise risk stratification than breast density assessment, according to ...

The breast cancer treatment landscape has evolved dramatically in the recent years due to advances in precision medicine, targeted therapy, antibody drug conjugates, and immunotherapies. We now have ...